Jeff Jonas
Stock Analyst at Gabelli
(n/a)
# 4,923
Out of 5,058 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Jeff Jonas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics | Initiated Coverage: Buy | $8 | $1.76 | +354.55% | 1 | Jun 15, 2026 | |
| ACH Accendra Health | Downgraded: Hold | n/a | $0.2615 | n/a | 1 | Feb 8, 2012 | |
| ANGO AngioDynamics | Upgraded: Hold | n/a | $11.58 | n/a | 1 | Feb 1, 2012 | |
| BSX Boston Scientific | Reiterated: Hold | n/a | $44.14 | n/a | 1 | Mar 16, 2010 | |
| MDT Medtronic | Reiterated: Hold | n/a | $95.45 | n/a | 1 | Mar 16, 2010 |
Acrivon Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.76
Upside: +354.55%
Accendra Health
Feb 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $0.2615
Upside: n/a
AngioDynamics
Feb 1, 2012
Upgraded: Hold
Price Target: n/a
Current: $11.58
Upside: n/a
Boston Scientific
Mar 16, 2010
Reiterated: Hold
Price Target: n/a
Current: $44.14
Upside: n/a
Medtronic
Mar 16, 2010
Reiterated: Hold
Price Target: n/a
Current: $95.45
Upside: n/a